This bill matters because it proposes to overturn a foundational piece of antitrust law that has shaped how businesses price and sell goods in the U.S. for decades. If it becomes law, it would change the rules of the game for how manufacturers deal with their customers, from massive retailers to independent local shops.

Voters should care because it could affect the prices they pay for everyday goods, including prescription drugs, and influence the survival and competitiveness of small businesses. Without the Robinson-Patman Act, proponents believe more aggressive price competition could lead to lower costs, while critics worry it could lead to market dominance by large players and potentially higher prices for some consumers.